trial · primary record
Biospecimen Collection
Acute Myeloid Leukemia
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 93 |
| Primary completion | 2027-03-31 |
| Primary endpoint | Minimal residual disease negative (MRDneg) complete remission (CR) rate |
| Registry ID | NCT06672146 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:02.863Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06672146
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.